Scarica l'app Stockscreener
12.62
1.45%
-0.1776
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.80
Aprire:
$12.87
Volume 24 ore:
1.84M
Relative Volume:
0.54
Capitalizzazione di mercato:
$2.52B
Reddito:
$3.90B
Utile/perdita netta:
$-413.00M
Rapporto P/E:
-6.0978
EPS:
-2.07
Flusso di cassa netto:
$365.00M
1 W Prestazione:
+3.23%
1M Prestazione:
-7.38%
6M Prestazione:
-0.28%
1 anno Prestazione:
-48.80%
Intervallo 1D:
$12.54
$12.88
Intervallo di 1 settimana:
$11.69
$12.98
Portata 52W:
$11.69
$24.86
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Confronta XRAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.62 | 2.49B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
436.06 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
183.50 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.26 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.22 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
266.23 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
Is the Conclusion of the SEC Investigation Changing the Investment Case for DENTSPLY SIRONA (XRAY)? - Yahoo Finance
Dentsply Sirona (XRAY) Stock Trades Up, Here Is Why - Yahoo Finance
SEC won’t recommend action against Dentsply Sirona after investigation - MassDevice
Developing predictive dashboards with DENTSPLY SIRONA Inc. data2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Can swing trading help recover from DENTSPLY SIRONA Inc. lossesTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Dentsply Sirona says SEC ends probe with no action; stock rises (XRAY:NASDAQ) - Seeking Alpha
Is New Commercial Leadership at DENTSPLY SIRONA (XRAY) Shaping Its Strategic and Investment Direction? - simplywall.st
Why DENTSPLY SIRONA Inc. stock remains a top recommendation2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com
Will DENTSPLY SIRONA Inc. stock maintain growth storyQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
How to escape a deep drawdown in DENTSPLY SIRONA Inc.Trade Ideas & High Accuracy Swing Entry Alerts - newser.com
DENTSPLY SIRONA (XRAY) Concludes SEC Investigation Without Penal - GuruFocus
SEC closes investigation into Dentsply Sirona with no enforcement action By Investing.com - Investing.com
Dentsply Sirona Won't Face Enforcement Action After SEC Ends Probe - MarketScreener
DENTSPLY SIRONA SEC Investigation Concludes Favorably - TipRanks
Why DENTSPLY SIRONA Inc. stock attracts high net worth investors2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Dentsply Sirona IncSEC concludes investigation of Dentsply SironaSEC filing - MarketScreener
Why DENTSPLY SIRONA Inc. (DY2) stock could be top winnerMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
What drives DENTSPLY SIRONA Inc DY2 stock priceConsumer Goods Stocks & These Picks Are Just One Breakout Away - earlytimes.in
DS World 2025 Las Vegas celebrates four decades of CEREC - Dental Tribune US
Will DENTSPLY SIRONA Inc. bounce back from current supportJuly 2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Dental Veneers Market Is Booming Rapidly from 2025 to 2032 | Dentsply Sirona, Kuraray America, Inc. - openPR.com
What makes DENTSPLY SIRONA Inc. stock attractive to growth fundsIndex Update & Precise Buy Zone Tips - newser.com
Why DENTSPLY SIRONA Inc. stock appeals to dividend seekers2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Heartland Value Fund is Monitoring Dentsply Sirona (XRAY) Amid a Deep Discount - Yahoo Finance
Is DENTSPLY SIRONA Inc a good long term investmentStraddle and Strangle Trades & Free Unlock Exclusive Strategies - earlytimes.in
Dental Autoclave Market Set to Significantly Grow from 2025 - openPR.com
Does DENTSPLY SIRONA Inc. show high probability of reboundAnalyst Downgrade & Real-Time Buy Signal Alerts - newser.com
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 52-Week LowShould You Sell? - MarketBeat
Dentsply Sirona stock hits 52-week low at $12.14 By Investing.com - Investing.com Canada
Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know - Yahoo Finance
Dentsply Sirona stock hits 52-week low at $12.14 - Investing.com
Pattern recognition hints at DENTSPLY SIRONA Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Aldo Denti joins Dentsply Sirona as chief commercial officer - Dental Tribune US
Will DENTSPLY SIRONA Inc. (DY2) stock issue positive guidanceLong Setup & Reliable Breakout Stock Forecasts - newser.com
Evercore ISI Group Maintains DENTSPLY SIRONA (XRAY) In-Line Recommendation - Nasdaq
Dentsply Sirona to Host Third Quarter Conference Call on November 6th - The Manila Times
DENTSPLY SIRONA to Host Investor Conference Call on November 6, 2025, for Q3 Financial Results - Quiver Quantitative
Nov. 6 webcast — Dentsply Sirona to host third-quarter results call at 8:30 AM ET - Stock Titan
DENTSPLY SIRONA (NASDAQ:XRAY) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
YieldBoost DENTSPLY SIRONA To 16.4% Using Options - Nasdaq
Evercore ISI Group Lowers Price Target for XRAY to $13.00 | XRAY Stock News - GuruFocus
U.S. Endodontics Devices Market: Strategic Growth and Emerging - openPR.com
Dentsply Sirona World 2025: Celebrating legacy and driving innovation - Oral Health Group
Navigating Growth in the Dental Handpieces Market: A Data-Driven Perspective - openPR.com
United States Medical Implants Market Growth & Industry Outlook - openPR.com
A Look at DENTSPLY SIRONA’s (XRAY) Valuation Following Appointment of New Chief Commercial Officer - Sahm
Could Leadership Changes at DENTSPLY SIRONA (XRAY) Signal a New Approach to Commercial Execution? - Sahm
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 4.3%Should You Sell? - MarketBeat
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.32%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):